Hovione enters partnership with Zerion Pharma
A partnership between global contract manufacturer Hovione and Zerion Pharma is a validation of the company’s technology that can increase the solubility of oral drugs, says the latter company’s CEO, Ole Wiborg, who is pleased about acquiring a global partner committed to delivering a number of projects.
BY CHRISTIAN BUNDGAARD, TRANSLATED BY DANIEL PEDERSEN
Zerion Pharma, which is focused on improving existing drugs’ effect by increasing the solubility of oral medications, has entered a strategic partnership with Hovione, which is a global contract development and manufacturing organization (CDMO) dealing with generic drugs.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Lundbeck preps for war against generic drugmakers in US
For subscribers
Catalent behind Novo Nordisk's supply issues, says media
For subscribers
